Women in Endocrinology: ENDO 2016

Boston, MA US

Women in Endocrinology (WE) Annual Meeting/Dinner

The Women in Endocrinology annual dinner meeting will be held on Friday, April 1st, 2016 from 6:30-10:00 pm in the Westin Boston Waterfront Hotel- Harbor Ballroom in Boston, MA. The meeting will begin with a chance to mingle and catch up with old friends over cocktails.  Our featured speaker will be Dr. Paula Johnson, Executive Director, Connors Center for Women’s Health and Gender Biology; Chief, Division of Women’s Health Brigham and Women’s Hospital; Professor of Medicine, Harvard Medical School; Professor of Epidemiology, Harvard T.H. Chan School of Public Health, who will present a talk entitled, “Sex and Gender in Health and Disease: a critical component on the quest for precision medicine”.

Target Audience

This continuing medical education activity should be of substantial interest to Adult and Pediatric Endocrinologists, Internal Medicine and Primary Care Physicians, Nurses, Nurse Practitioners and Fellows.

Learning Objectives

  • Explain the impact of sex and gender on the risk and outcome of a disease.
  • Identify strategies to include adequate number of women, female animals and female cells in research.
  • Contribute to advancements in precision medicine through appropriate consideration of sex and gendered determinants of health.

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
General Endocrinology
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credits
  • 0.50 CME Certificate of Participation
Course opens: 
Course expires: 
Event starts: 
04/01/2016 - 6:30pm
Event ends: 
04/01/2016 - 10:00pm
The Westin Boston Waterfront - Harbor Ballroom
425 Summer St
Boston, MA 02210
United States

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The planners/faculty reported the following financial relationship(s): Dana Erickson, MD is a Coinvestigator for Novartis Corporation Pharmaceuticals; Paula A. Johnson, MD is a Board member of West Pharmaceuticals; Ildinko Lingvay, MD, MPH, MSCS, is an Advisory Group Member for NovoNordisk and a Clinical Researcher for NovoNordisk, Pfizer, Inc., and GI Dynamics, Inc.; Geralyn Lambert Messerlian, PhD is a Researcher for Natera, Ansh Labs, and Fujirebio 

The following planners reported no financial relationships: Rona Carroll, PhD; Kimberly H. Cox, PhD; Dana Erickson, MD; Dana Gaddy, PhD; Janice Kerr MD; Dolores J. Lamb, PhD; B. Gisella Carranza Leon, MD; Karen Klahr Miller, MD; Maria Theresa Estrella Montales, MD; Lori Raetzman, PhD; Mary Rhee, MD; Stephanie Seminara, MD; Carol Sartorius PhD; Whitney Woodmansee, MD 
Endocrine Society staff associated with the development of content for this activity reported no financial relationships.
This disclosure information is included for transparency purposes. However, during a review of these financial relationships, it was determined that the relationships do not create any conflicts of interest in the development or delivery of this activity. 

Available Credit

  • 0.50 AMA PRA Category 1 Credits
  • 0.50 CME Certificate of Participation